1. Home
  2. VNDA vs OBT Comparison

VNDA vs OBT Comparison

Compare VNDA & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • OBT
  • Stock Information
  • Founded
  • VNDA 2002
  • OBT 1892
  • Country
  • VNDA United States
  • OBT United States
  • Employees
  • VNDA N/A
  • OBT N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • OBT Major Banks
  • Sector
  • VNDA Health Care
  • OBT Finance
  • Exchange
  • VNDA Nasdaq
  • OBT Nasdaq
  • Market Cap
  • VNDA 237.9M
  • OBT 267.9M
  • IPO Year
  • VNDA 2006
  • OBT N/A
  • Fundamental
  • Price
  • VNDA $4.22
  • OBT $25.48
  • Analyst Decision
  • VNDA Strong Buy
  • OBT Buy
  • Analyst Count
  • VNDA 2
  • OBT 1
  • Target Price
  • VNDA $16.50
  • OBT $35.50
  • AVG Volume (30 Days)
  • VNDA 500.0K
  • OBT 21.7K
  • Earning Date
  • VNDA 05-07-2025
  • OBT 04-30-2025
  • Dividend Yield
  • VNDA N/A
  • OBT 1.88%
  • EPS Growth
  • VNDA N/A
  • OBT N/A
  • EPS
  • VNDA N/A
  • OBT 2.41
  • Revenue
  • VNDA $201,351,000.00
  • OBT $100,883,000.00
  • Revenue This Year
  • VNDA $14.36
  • OBT $12.69
  • Revenue Next Year
  • VNDA $44.53
  • OBT $6.00
  • P/E Ratio
  • VNDA N/A
  • OBT $10.68
  • Revenue Growth
  • VNDA 13.37
  • OBT N/A
  • 52 Week Low
  • VNDA $3.85
  • OBT $20.97
  • 52 Week High
  • VNDA $6.75
  • OBT $33.06
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 41.17
  • OBT 58.45
  • Support Level
  • VNDA $4.20
  • OBT $22.81
  • Resistance Level
  • VNDA $4.64
  • OBT $26.67
  • Average True Range (ATR)
  • VNDA 0.17
  • OBT 1.40
  • MACD
  • VNDA 0.01
  • OBT 0.38
  • Stochastic Oscillator
  • VNDA 20.75
  • OBT 74.36

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

Share on Social Networks: